World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
112
Citations
48825
World Ranking
810
National Ranking
493

Medicine

D-Index
116
Citations
50647
World Ranking
4347
National Ranking
2370

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Nancy E. Kemeny is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research encompasses a broad range of topics within medicine, with a particular focus on surgery, oncology, and hepatology.

The scientist's primary fields of study include:

  • Medicine

Within this broad domain, Kemeny has contributed extensively to several subfields:

  • Surgery
  • Oncology
  • Hepatology
  • Pulmonary and Respiratory Medicine
  • Pathology and Forensic Medicine

The main topics of Kemeny's work illustrate a focused engagement with specific types of cancers and related medical conditions:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Pancreatic and Hepatic Oncology Research
  • Organ Transplantation Techniques and Outcomes
  • Gallbladder and Bile Duct Disorders
  • Viral-associated cancers and disorders

The scientist has authored several recent papers demonstrating ongoing research activity. Notable publications include:

  • A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers, 2021, JNCI Journal of the National Cancer Institute
  • Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma, 2021, Hepatology
  • Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer, 2021, Clinical Cancer Research
  • Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study, 2020, Clinical Colorectal Cancer
  • Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment, 2022, European Journal of Cancer

Kemeny's frequent co-authors include:

  • T. Peter Kingham
  • William R. Jarnagin
  • Andrea Cercek
  • Jeffrey A. Drebin
  • Alice C. Wei

The scientist's work is regularly published in several prominent medical journals, with multiple contributions particularly in the following venues:

  • Annals of Surgical Oncology
  • HPB
  • Journal of Clinical Oncology
  • Journal of Surgical Oncology
  • Clinical Cancer Research

Best Publications

  • The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress

    R.K. Portenoy;H.T. Thaler;A.B. Kornblith;J. McCarthy Lepore

  • ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

    Gershon Y. Locker;Stanley R Hamilton;Jules Harris;John M. Jessup

  • Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry

    Ki Young Chung;Jinru Shia;Nancy E. Kemeny;Manish Shah

  • Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure

    James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong

  • 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    Robert C. Bast;Peter Ravdin;Daniel F. Hayes;Susan Bates

  • CD133 expression is not restricted to stem cells, and both CD133 + and CD133 – metastatic colon cancer cells initiate tumors

    Sergey V. Shmelkov;Jason M. Butler;Andrea T. Hooper;Adilia Hormigo

  • Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

    Nancy Kemeny;Ying Huang;Alfred M. Cohen;Weiji Shi

  • Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

    Daniel F. Hayes;Daniel F. Hayes;Robert C. Bast;Christopher E. Desch;Herbert Fritsche

  • Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

    Itaru Endo;Mithat Gonen;Adam C. Yopp;Kimberly M. Dalal

  • Symptom prevalence, characteristics and distress in a cancer population

    R. K. Portenoy;H. T. Thaler;A. B. Kornblith;J. McCarthy Lepore

  • Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

    Nancy Kemeny;John Daly;Bonnie Reichman;Nancy Geller

  • Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer

    Rona Yaeger;Walid K. Chatila;Marla D. Lipsyc;Jaclyn F. Hechtman

  • Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

    P Piedbois;M Buyse;N Kemeny

  • Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study

    Leonard B. Saltz;Heinz-Josef Lenz;Hedy L. Kindler;Howard S. Hochster

  • Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment

    George A. Poultsides;Elliot L. Servais;Leonard B. Saltz;Sujata Patil

  • Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention.

    Maeve A. Lowery;Ryan Ptashkin;Emmet Jordan;Michael F. Berger

  • Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)

    Nancy E. Kemeny;Donna Niedzwiecki;Donna R. Hollis;Heinz-Josef Lenz

  • Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal Carcinoma

    Gregory D. Leonard;Baruch Brenner;Nancy E. Kemeny

  • Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

    J. A. Conti;N. E. Kemeny;L. B. Saltz;Ying Huang

  • SPECIAL ARTICLE Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers

    Daniel F. Hayes;Robert C. Bast;Christopher E. Desch;Nancy E. Kemeny

Frequent Co-Authors

Michael I. D’Angelica
Michael I. D’Angelica Memorial Sloan Kettering Cancer Center
William R. Jarnagin
William R. Jarnagin Memorial Sloan Kettering Cancer Center
Yuman Fong
Yuman Fong City Of Hope National Medical Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
Ronald P. DeMatteo
Ronald P. DeMatteo University of Pennsylvania
Peter J. Allen
Peter J. Allen Duke University
T. Peter Kingham
T. Peter Kingham Memorial Sloan Kettering Cancer Center
Philip B. Paty
Philip B. Paty Memorial Sloan Kettering Cancer Center
Jinru Shia
Jinru Shia Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always require a traditional MD pathway. Today, rn to bsn online programs are a practical option for registered nurses aiming to advance with greater flexibility and affordability. For those holding a non-nursing bachelor’s degree, accelerated non nursing bachelor's to msn online programs offer a direct route into advanced practice nursing roles.

If you’re looking for accessible entry points into the healthcare field, adn programs can help you start your nursing career quickly. In addition, allied health roles are in high demand and often require less schooling. Training at reputable medical billing and coding schools online can open doors to administrative and support positions that are vital to patient care.

Whether you seek hands-on clinical practice, administration, or a faster route to healthcare employment, a range of accredited online programs can suit your goals and lifestyle.

Best Scientists Citing Nancy E. Kemeny

Trending Scientists